BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Cassava Sciences Inc. (SAVA)

1 post

Biotech NewsCassava Sciences (SAVA) Secures $149M to Support Simufilam Trials Into 2026

  • BioTech Health X
  • December 22, 2024
Cassava Sciences Inc. (SAVA) is a clinical-stage biotechnology company at the forefront of advancing treatments for Alzheimer’s disease,…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Is Iovance Biotherapeutics (IOVA) a Smart Cancer Therapy Stock to Buy Right Now?
  • Is Recursion Pharmaceuticals (RXRX) a Good AI Biotech Stock to Buy for the Future?
  • Here’s What Makes Rocket Pharmaceuticals (RCKT) a Biotech Stock With Serious Comeback Potential
  • Could Verastem Oncology (VSTM) Be One of the Most Interesting Oncology Stocks Right Now?
  • Is Geron Corporation (GERN) a Smart Biotech Stock to Buy for Long-Term Investors?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • June 4, 2026
    Is Iovance Biotherapeutics (IOVA) a Smart Cancer Therapy Stock to Buy Right Now?
    • June 4, 2026
    Is Recursion Pharmaceuticals (RXRX) a Good AI Biotech Stock to Buy for the Future?
    • June 4, 2026
    Here’s What Makes Rocket Pharmaceuticals (RCKT) a Biotech Stock With Serious Comeback Potential
    • June 4, 2026
    Could Verastem Oncology (VSTM) Be One of the Most Interesting Oncology Stocks Right Now?
    • June 4, 2026
    Is Geron Corporation (GERN) a Smart Biotech Stock to Buy for Long-Term Investors?
Recent Posts
  • Is Ovid Therapeutics (OVID) a Good Biotech Stock to Buy Before the Market Notices?
    • June 4, 2026
  • Is Caribou Biosciences (CRBU) a Smart Gene-Editing Stock to Buy for Long-Term Growth?
    • June 4, 2026
  • Here’s What Makes NRx Pharmaceuticals (NRXP) a Speculative Biotech Stock Traders Are Watching
    • June 4, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (966)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top